第61回日本神経学会学術大会

セッション情報

【誌上開催】一般演題口演セッション

[O-31] 一般演題口演セッション31
治療創薬・再生医療1 E

植田 光晴1, David Adams2, Alejandra González-Duarte3, Elizabeth A Mauricio4, Thomas H Brannagan5, Teresa Coelho6, Jonas Wixner7, Hartmut Schmidt8, Erhan Berber9, Marianne Sweetser9, Matthew T White9, Jing Jing Wang9, Michael Polydefkis10 (1.熊本大学病院 脳神経内科, 2.National Reference Center for FAP (NNERF)/ APHP/ INSERM U 1195/ CHU Bicêtre, Le Kremlin Bicêtre, France, 3.Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico, 4.Mayo Clinic, Jacksonville, FL, USA, 5.Department of Neurology, Columbia University, New York City, NY, USA, 6.Centro Hospitalar Universitário do Porto, Portugal, 7.Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden, 8.University Hospital Muenster, Muenster, Germany, 9.Alnylam Pharmaceuticals, Cambridge, USA, 10.Johns Hopkins University, Baltimore, USA)

林 幼偉1, 成田 智子2, 王子 聡3, 宮本 勝一4, 髙嶋 博5, 槍沢 公明6, 新野 正明7, 横山 和正8, 渡邊 修9, 諏訪園 秀吾10, 森 雅弘11, 芳川 浩男12, 松尾 秀徳13 (1.国立精神・神経医療研究センター, 2.国立病院機構長崎川棚医療センター, 3.埼玉医科大学総合医療センター, 4.近畿大学医学部附属病院, 5.鹿児島大学病院, 6.総合花巻病院, 7.国立病院機構北海道医療センター, 8.順天堂大学医学部附属順天堂医院, 9.鹿児島市立病院, 10.沖縄病院, 11.千葉大学医学部附属病院, 12.兵庫医科大学病院, 13.国立病院機構長崎病院)

田中 寛大1,2, 古賀 政利1, Keon-Joo Lee3, Beom Joon Kim3, Eun Lyeong Park4, Juneyoung Lee4, 溝口 忠孝1, 吉村 壮平1, Jae-Kwan Cha5, Byung-Chul Lee6, 中原 仁2, 鈴木 則宏2, 豊田 一則1,2 (1.国立循環器病研究センター, 2.慶應大学, 3.Seoul National University Bundang Hospital, 4.Korea University, 5.Dong-A University Hospital, 6.Hallym University Sacred Heart Hospital)

Anthony Traboulsee1, Benjamin Greenberg2, Jeffrey L. Bennett3, Lech Szczechowski4, Edward Fox5, Svitlana Shkrobot6, Takashi Yamamura7, Yusuke Terada8, Yuichi Kawata8, Pádraig Wright9, H.-christian Von Büdingen10, Gaelle Klingelschmitt10, Athos Gianella-borradori11, Brian G. Weinshenker12 (1.University of British Columbia, 2.University of Texas Southwestern Medical Center, 3.University of Colorado School of Medicine, 4.Silesian Centre of Neurology, 5.Central Texas Neurology Consultants, 6.Ternopil State Medical University, 7.National Center of Neurology and Psychiatry, 8.Chugai Pharmaceutical Co., Ltd, Tokyo, 9.Chugai Pharma Europe Ltd. London, 10.F. Hoffmann-La Roche Ltd, 11.Chugai Pharma USA LLC, 12.Mayo Clinic)

中島 一郎1, Kazuo Fujihara2,3, Achim Berthele4, Ho Jin Kim5, Michael Levy6,7, Celia Oreja-Guevara8, Jacqueline Palace9, Sean J. Pittock10, Murat Terzi11, Natalia Totolyan12, Shanthi Viswanathan13, Kai-Chen Wang14,15, Amy Pace16, Marcus Yountz16, Larisa Miller16, Imran Tanvir16, Róisín Armstrong16, Dean M. Wingerchuk10 (1.東北医科薬科大学医学部 老年神経内科学, 2.東北大学医学部 神経内科学, 3.福島県立医科大学 多発性硬化症治療学, 4.Technical University of Munich, 5.Research Institute and Hospital, Goyang, 6.Johns Hopkins University, 7.Massachusetts General Hospital, 8.Hospital Universitario Clínico San Carlos, 9.John Radcliffe Hospital, 10.Mayo Clinic, 11.Ondokuz Mayis University, 12.First Pavlov State Medical University of St Petersburg, 13.Kuala Lumpur Hospital, 14.Cheng-Hsin General Hospital, 15.National Yang Ming University, 16.Alexion Pharmaceuticals)

Krishnan Ramanathan1, Stephen L. Hauser2, Amit Bar-or3, Jeffrey Cohen4, Giancarlo Comi5, Jorge Correale6, Patricia K. Coyle7, Anne H. Cross8, Jérôme De. Seze9, Xavier Montalban Et Al.10 (1.Novartis Pharma AG, 2.Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, 3.Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, 4.Neurological Institute, Cleveland Clinic, 5.University Vita-Salute San Raffaele, 6.Institute for Neurological Research Dr. Raul Carrea, 7.Stony Brook University, 8.Washington University School of Medicine, 9.University Hospital of Strasbourg, 10.St Michael's Hospital, University of Toronto)

Jerome De Seze1, Brian G. Weinshenker2, Yusuke Terada3, Yuichi Kawata3, Athos Gianella-borradori4, H.-christian Von Büdingen5, Gaelle Klingelschmitt5, Anthony Traboulsee6, Takashi Yamamura7 (1.Hôpital de Hautepierre, 2.Mayo Clinic, 3.Chugai Pharmaceutical Co., Ltd, Tokyo, 4.Chugai Pharma USA LLC, 5.F. Hoffmann-La Roche Ltd, 6.University of British Columbia, 7.National Center of Neurology and Psychiatry)